IMRN
Immuron Limited
NASDAQ · Healthcare · Biotechnology · AU
$1.80
+62.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.83x
- Price / sales
- 1.60x
- Price / cash flow
- -3.15x
Enterprise value
- Enterprise value
- $8.0M
- EV / sales
- 0.88x
- EV / EBITDA
- -1.24x
- EV / EBIT
- -1.24x
- Market cap
- $14.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026